It has excellent nucleoside and nucleotide degradation ability, can decompose most of the uric acid synthesis precursors, reduce the body's absorption of uric acid synthesis precursors, and can also directly and efficiently decompose uric acid in the intestines, and reduce serum endotoxin levels and inhibit Xanthine oxidase activity further inhibits the production of uric acid and relieves inflammation, etc.

BL21 can scavenge free radicals and has antioxidant activity. It can also improve metabolic syndrome and regulate intestinal flora, indicating that BL21 can enhance the effect of probiotics through synergistic effects.

It has strong antibacterial ability and has the potential to exert synergistic effects by regulating intestinal bacteria.

It can inhibit lipid accumulation, improve glucose and lipid metabolism, and can also remove free radicals and exert antioxidant activity.

The uric acid-lowering function of this formula (Lactobacillus gasseri LG08, Bifidobacterium longum subsp. longum BL21, Ligilactobacillus salivarius LS97 and Lactiplantibacillus plantarum Lp90) was verified through animal experiments. The results showed that the compound probiotic powder can significantly It can significantly reduce the uric acid content in the serum of hyperuricic acid model rats. It can also effectively reduce the levels of lipopolysaccharide and pro-inflammatory factor IL-6 in hyperuricic acid rats, increase the content of anti-inflammatory factor IL-10, enhance the intestinal mucosal barrier, and relieve inflammation.